META
Meta Platforms, Inc.
META has the edge over UCL overall, supported by lower modeled downside and stronger fundamentals.
UCL
uCloudlink Group Inc.
UCL's outlook is improving, though it still trails on the overall score.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
UCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Strong |
UCL's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
UCL PE Valuation
UCL has no meaningful PE right now: it lost money over the past year.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
UCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| High |
UCL has the edge over META on the outlook, with more favorable profitability expectations.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the stronger earnings trend. Trailing diluted EPS is up 30% for META versus UCL down 20%.
UCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | $0.12 | +$0.27 |
| Q1 2024 | $0.03 | +$0.36 |
| Q4 2023 | $0.08 | +$0.74 |
| Q3 2023 | $0.10 | +$1.27 |
| Q2 2023 | -$0.15 | +$1.12 |
| Q1 2023 | -$0.33 | +$1.02 |
| Q4 2022 | -$0.66 | +$0.96 |
| Q3 2022 | -$1.17 | +$0.35 |
UCL has returned to profit: it earned $0.12 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over UCL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over UCL on profitability, with a higher operating margin.
UCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.2M | -5.9% |
| Q1 2026 | $16.9M | -10% |
| Q4 2025 | $22.3M | -14% |
| Q3 2025 | $21.2M | -16% |
| Q2 2025 | $19.4M | -13% |
| Q1 2025 | $18.7M | +3.4% |
| Q4 2024 | $26M | +19% |
| Q3 2024 | $25.2M | +5.6% |
UCL's revenue has slid since its 2019 peak: $18M last quarter, down 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -16% | -20 points |
| Q1 2026 | -16% | -13 points |
| Q4 2025 | 8.5% | +15 points |
| Q3 2025 | 0.6% | -13 points |
| Q2 2025 | 4.2% | -5.9 points |
| Q1 2025 | -2.5% | -5.3 points |
| Q4 2024 | -6.6% | +1.9 points |
| Q3 2024 | 13% | -0.7 points |
UCL's operating margin was −16% last quarter, down 20 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over UCL on cash generation, producing positive trailing cash flow while its opponent burns cash.
UCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.1M | -$2M |
| Q1 2026 | -$8.7M | -$8.7M |
| Q4 2025 | $4.4M | +$7.8M |
| Q3 2025 | -$1.4M | -170% |
| Q2 2025 | -$1.1M | -135% |
| Q1 2025 | -$64K | -105% |
| Q4 2024 | -$3.5M | -$80K |
| Q3 2024 | $2M | +1.2% |
UCL has burned cash in six of the last eight quarters: −$9M over the past year, against −$3M the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over UCL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
UCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +163K shares |
| 1 year | +1.3% | +478K shares |
| 3 years | +33% | +9.3M shares |
| 5 years | +44% | +11.6M shares |
UCL has 38M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
UCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -4.0x | Net Cash |
| Q2 2024 | -3.4x | Net Cash |
| Q1 2024 | -7.9x | Net Cash |
| Q4 2023 | -4.4x | Net Cash |
UCL has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
UCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.1 | Oversold |
| Stochastic | 4.7 | Oversold |
UCL's weekly RSI is 19 (oversold) and its Stochastic is 5 (oversold).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
UCL PE vs Communication Services Sector
| Metric | UCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
UCL has no meaningful PE right now: it lost money over the past year.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has the edge over UCL on trend strength, trading above more of its moving averages.
UCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 12% below |
| 20 week MA | $0.50 | 56% below |
| 50 week MA | $1.07 | 79% below |
| 100 week MA | $1.49 | 85% below |
| 200 week MA | $1.90 | 88% below |
UCL is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over UCL on returns for 2026, with the stronger performance.
UCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $10.4 | -37% |
| 2021 | $10.4 | $3.30 | -68% |
| 2022 | $3.30 | $3.97 | +20% |
| 2023 | $3.97 | $1.75 | -56% |
| 2024 | $1.75 | $2.40 | +37% |
| 2025 | $2.40 | $2.05 | -15% |
| 2026 YTD | $2.05 | $0.22 | -89% |
UCL has finished lower in four of the last six years. It's down 89% so far in 2026.